A detailed history of Planning Capital Management Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Planning Capital Management Corp holds 722 shares of NVO stock, worth $103,296. This represents 0.07% of its overall portfolio holdings.

Number of Shares
722
Previous 725 0.41%
Holding current value
$103,296
Previous $75 Million 23.6%
% of portfolio
0.07%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$102.11 - $135.92 $306 - $407
-3 Reduced 0.41%
722 $92.7 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $63,640 - $76,451
725 New
725 $75 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.